Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07839871 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease

Name: Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease — clinical trial record (NCT07839871)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 3

SponsorPfizer

Started2026-09-28

View on ClinicalTrials.gov ↗

Pfizer

431 trials monitored

See 32 trials at risk

The purpose of the study is to evaluate the safety, tolerability, and immunogenicity of RSVpreF in children 5 to \<18 years of age at high risk for RSV disease, including those who are immunocompromised.

Trial Details

NCT Number	NCT07839871
Lead Sponsor	Pfizer
Conditions	Respiratory Syncytial Virus (RSV)
Enrollment	920 participants
Start Date	2026-09-28
Primary Completion	2031-04-01 (estimated)
Study Completion	2031-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-24